# Dermorphin

*Also known as: Dermorphin*

Potent amphibian-derived opioid peptide; research compound for analgesia.

## Overview

Dermorphin is a potent amphibian-derived opioid peptide first isolated from frog skin, acting as a selective mu-opioid receptor agonist. In animal studies it is many times more potent than morphine at the receptor, which is exactly what makes it hazardous as well as interesting: it carries the full opioid risk profile including respiratory depression, dependence, and fatal overdose, and there is no approved human use. It is a strictly research-only compound with no human clinical data, and its very short half-life and extreme potency make non-clinical use especially dangerous. Values shown in the plotter are rough estimates, not measured human PK. We list it for catalog completeness only and do not frame it as a therapy, a supplement, or a safer alternative to prescription opioids.

## Pharmacokinetics

- **Model tier:** simple
- **Half-life:** 0.0 days (0.48 hours)
- **Bioavailability:** 40%

## Dosing

- **Default dose:** 0.01 mg
- **Typical range:** 0.005–0.02 mg
- **Units:** ng/mL

## Source

- **Label:** Estimated
- **Notes:** Amphibian opioid peptide; potent μ-opioid agonist, very short acting.

**Tags:** recovery-healing

---

**Canonical URL:** https://anabolicdex.com/compounds/dermorphin
**Plot:** https://anabolicdex.com/plot?compound=dermorphin